ECTE Insider Trading - Echo Therapeutics Inc

Insider Shares

3,145,853 shares

Insider Sentiment Score

The Insider Sentiment Score finds the companies being bought by corporate insiders.

It is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of insider accumulation. The scoring model uses a combination of the net number of insiders buying the prior 90 days, the total shares bought as a percentage of float, and the total shares owned by insiders. The number ranges from 0 to 100, with higher numbers indicating a higher level of accumulation to its peers, and 50 being the average.

Update Frequency: Daily

See Insiders Top Picks, which provides a list of companies with highest insider accumulation.

See Highest Ranking Stocks

Officer Sentiment Score

The Officer Sentiment Score finds companies being bought by Corporate Officers.

By definition Corporate Officers are Corporate Insiders, but unlike some of the other Insiders (10% Shareholders and Board Members), Officers work for the company on a daily basis, and they user their own money when trading. (10% Shareholders and Board Members are often fund managers managing other people’s money.) As such, insider trades made by Officers are much more significant and should be treated appropriately.

Like the Insider Sentiment Score, the Officer Sentiment Score is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of officer accumulation.

Update Frequency: Daily

See Insiders Top Picks, which provides a list of companies with highest insider sentiment.

See Highest Ranking Stocks

Key Insider Metrics

This card shows how the company ranks along various insider metrics. The percentile rank shows how this company compares to other companies in the US markets. Higher rankings are indicative of better situations.

For example, it is generally accepted that insider buying is a positive indicator, so companies with more insider buying would rank higher than companies with less insider buying (or even insider selling).

Net Number of Insiders Buying (Rank)

N/A

Net Number of Insiders Buying is the total number of insiders buying minus the total number of insiders selling in the last 90 days. The percentile rank is shown here (range from 0 to 100%).

Percent of Float Bought by Insiders (Rank)

N/A

Percent of Float Bought by Insiders is the total number of shares purchased by insiders minus the total number of shares sold by insiders in the last 90 days, divided by the total float and multiplied by 100.

Insider Trading Chart

Echo Therapeutics Inc insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

Insider Roster and Profitability Metrics

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings. Additionally, when possible we provide the historical trade performance for the insider. The historical trade performance is a weighted average of the performance of actual open-market purchase transactions made by the insider. For more information on how this is calculated, watch this YouTube webinar.

See our leaderboard of most profitable insider traders.

Insider	Avg Profit (%)	Shares Owned	Split Adjusted

Report errors via our new Insider Auditing Tool

Track Records of Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ECTE / Echo Therapeutics Inc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2015-05-20	Hollander Scott Wayne	8,000	1.4800	8,000	1.4800	11,840	162	1.8800	3,200	27.03
2015-05-20	SCHOENBART ALAN WAYNE	2,500	1.4400	2,500	1.4400	3,600
2014-06-30	Nordlicht Mark	55,083	2.2000	55,083	2.2000	121,183
2014-06-27	Nordlicht Mark	10,656	2.2000	10,656	2.2000	23,443
2014-06-26	Nordlicht Mark	15,000	2.2000	15,000	2.2000	33,000
2014-06-25	Nordlicht Mark	2,300	2.2000	2,300	2.2000	5,060
2014-06-24	Nordlicht Mark	386	2.2000	386	2.2000	849

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ECTE / Echo Therapeutics Inc Insider Trades

Track Records of Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ECTE / Echo Therapeutics Inc. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

File Date	Trade Date	Form	Insider	Ticker	Security Title	Code	Direct	Exercise Price	Unit Price	Units Changed	Value Changed (1K)	Remaining Options	Remaining Shares
2017-03-23	2017-03-21	4	GOLDBERG SHEPARD M	ECTE	Common Stock, par value $.01	A - Award	D			25,000			32,250
2017-03-23	2017-03-21	4	GOLDBERG MICHAEL M	ECTE	Comon Stock, par value $.01	A - Award	D			25,000			39,500
2017-03-22	2017-03-21	4	SCHOENBART ALAN WAYNE	ECTE	Stock Option (Right to Buy)	A - Award	D	0.16		500,000		500,000
2017-03-22	2017-03-21	4	SCHOENBART ALAN WAYNE	ECTE	Common Stock, par value $.01	A - Award	D			100,000			174,500
2017-03-22	2016-11-25	4	SCHOENBART ALAN WAYNE	ECTE	Common Stock, par value $.01	F - Taxes	D		0.3400	-28,000	-10		74,500
2016-11-23	2016-03-01	4/A	SCHOENBART ALAN WAYNE	ECTE	Common Stock	A - Award	D			100,000			102,500
2016-03-03	2016-03-01	4	GOLDBERG SHEPARD M	ECTE	Options (Right to Buy)	A - Award	D	1.12		150,000		37,500
2016-03-03	2016-03-01	4	SCHOENBART ALAN WAYNE	ECTE	Options (Right to Buy)	A - Award	D	1.12		150,000		50,000
2016-03-03	2016-03-01	4	SCHOENBART ALAN WAYNE	ECTE	Common Stock	A - Award	D			100,000			102,500
2016-03-03	2016-03-01	4	Hollander Scott Wayne	ECTE	Options (Right to Buy)	A - Award	D	1.12		175,000		58,333
2016-03-03	2016-03-01	4	Hollander Scott Wayne	ECTE	Common Stock	A - Award	D			150,000			158,000
2016-03-03	2016-03-01	4	Edelman Elazer R	ECTE	Options (Right to Buy)	A - Award	D	1.12		150,000		37,500
2016-03-03	2016-03-01	4	GOLDBERG MICHAEL M	ECTE	Options (Right to Buy)	A - Award	D	1.12		150,000		37,500
2015-05-20	2015-05-20	4	SCHOENBART ALAN WAYNE	ECTE	Common Stock	P - Purchase	D		1.4400	2,500	4		2,500
2015-05-20	2015-05-20	4	Hollander Scott Wayne	ECTE	Common Stock	P - Purchase	D		1.4800	8,000	12		8,000
2015-05-18	2014-12-18	4/A	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Common Stock	J - Other	I			-447,590			272,603
2015-05-18	2014-12-18	4/A	Nordlicht Mark By Platinum Partners Value Arbitrage Fund L.P.	ECTE	Common Stock	J - Other	I			-1,052,410			511,273
2015-01-12	2015-01-07	4	GOLDBERG MICHAEL M	ECTE	Stock Option	A - Award	D	1.62	1.6200	150,000	243	150,000
2015-01-12	2015-01-07	4	GOLDBERG SHEPARD M	ECTE	Stock Option	A - Award	D	1.62	1.6200	150,000	243	150,000
2014-12-22	2014-12-18	4	Nordlicht Mark By Platinum Partners Value Arbitrage Fund L.P.	ECTE	Warrants	P - Purchase	I	3.00		1		1
2014-12-22	2014-12-18	4	Nordlicht Mark By Platinum Partners Value Arbitrage Fund L.P.	ECTE	Series F Preferred Stock	P - Purchase	I		1.1900	420,168	500	420,168
2014-07-14	2014-07-10	4	GOLDBERG SHEPARD M	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.11		28,000		28,000
2014-07-14	2014-07-10	4	GOLDBERG SHEPARD M	ECTE	Common Stock	A - Award	D			7,250			7,250
2014-07-01	2014-06-30	4	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Common Stock	P - Purchase	I		2.2000	55,083	121		678,452
2014-07-01	2014-06-27	4	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Common Stock	P - Purchase	I		2.2000	10,656	23		623,369
2014-06-27	2014-06-26	4	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Common Stock	P - Purchase	I		2.2000	15,000	33		612,713
2014-06-27	2014-06-25	4	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Common Stock	P - Purchase	I		2.2000	2,300	5		597,713
2014-06-24	2014-06-24	4	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Common Stock	P - Purchase	I		2.2000	386	1		595,413
2014-06-24	2014-06-23	4	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Common Stock	P - Purchase	I		2.2000	85	0		595,027
2014-06-24	2014-06-20	4	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Common Stock	P - Purchase	I		2.1996	16,490	36		594,942
2014-03-17	2014-02-28	4	GOLDBERG MICHAEL M	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	3.19		56,000		56,000
2014-03-17	2014-02-28	4	GOLDBERG MICHAEL M	ECTE	Comon Stock	A - Award	D			14,500			14,500
2014-03-10		3	GOLDBERG MICHAEL M Shares are held in trust for the Reporting Person's children.	ECTE	Common Stock		I						79,600
2014-03-10		3	GOLDBERG MICHAEL M Shares are held in trust for the Reporting Person's children.	ECTE	Common Stock		I						79,600
2014-01-03	2013-12-18	4	ENRIGHT VINCENT D	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.98		56,000		70,500
2014-01-03	2013-12-18	4	ENRIGHT VINCENT D	ECTE	Common Stock	A - Award	D			14,500			28,200
2014-01-03	2013-12-18	4	GRIECO WILLIAM	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.98		56,000		60,500
2014-01-03	2013-12-18	4	GRIECO WILLIAM	ECTE	Common Stock	A - Award	D			14,500			38,200
2014-01-03	2013-12-18	4	SMITH JAMES FRANCIS	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.98		56,000		60,500
2014-01-03	2013-12-18	4	SMITH JAMES FRANCIS	ECTE	Common Stock	A - Award	D			14,500			22,900
2013-12-12	2013-12-10	4	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Warrants	P - Purchase	I	2.75		1		1
2013-12-12	2013-12-10	4	Nordlicht Mark By Platinum Partners Value Arbitrage Fund L.P.	ECTE	Warrants	P - Purchase	I	2.75		1		1
2013-12-12	2013-12-10	4	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Series E Preferred Stock	P - Purchase	I		2.7500	349,723	962	349,723
2013-12-12	2013-12-10	4	Nordlicht Mark By Platinum Partners Value Arbitrage Fund L.P.	ECTE	Series E Preferred Stock	P - Purchase	I		2.7500	1,398,890	3,847	1,398,890
2013-12-12	2013-12-10	4	Nordlicht Mark By Platinum Partners Liquid Opportunity Master Fund L.P.	ECTE	Common Stock	P - Purchase	I		2.7500	13,914	38		578,452
2013-12-12	2013-12-10	4	Nordlicht Mark By Platinum Partners Value Arbitrage Fund L.P.	ECTE	Common Stock	P - Purchase	I		2.7500	55,655	153		507,824
2013-10-02	2013-10-01	4	ENRIGHT VINCENT D	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.76		1,500		14,500
2013-10-02	2013-10-01	4	ENRIGHT VINCENT D	ECTE	Common Stock	A - Award	D			400			13,700
2013-10-02	2013-10-01	4	GRIECO WILLIAM	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.76		1,500		4,500
2013-10-02	2013-10-01	4	GRIECO WILLIAM	ECTE	Common Stock	A - Award	D			400			23,700
2013-10-02	2013-10-01	4	SMITH JAMES FRANCIS	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.76		1,500		4,500
2013-10-02	2013-10-01	4	SMITH JAMES FRANCIS	ECTE	Common Stock	A - Award	D			400			8,400
2013-10-02	2013-10-01	4	Doman Robert F	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.76		1,500		4,500
2013-10-02	2013-10-01	4	Doman Robert F	ECTE	Common Stock	A - Award	D			400			4,700
2013-07-22		3	Platinum-Montaur Life Sciences, LLC	ECTE	Common Stock		D						452,169
2013-07-22		3	Platinum-Montaur Life Sciences, LLC	ECTE	Common Stock		D						564,538
2013-07-09	2013-07-01	4/A	GRIECO WILLIAM	ECTE	Common Stock	A - Award	D			400			23,300
2013-07-09	2013-07-01	4/A	SMITH JAMES FRANCIS	ECTE	Common Stock	A - Award	D			400			8,000
2013-07-09	2013-07-01	4/A	Doman Robert F	ECTE	Common Stock	A - Award	D			400			4,300
2013-07-09	2013-07-01	4/A	ENRIGHT VINCENT D	ECTE	Common Stock	A - Award	D			400			13,300
2013-07-02	2013-07-01	4	ENRIGHT VINCENT D	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.49		1,500		116,500
2013-07-02	2013-07-01	4	ENRIGHT VINCENT D	ECTE	Common Stock	A - Award	D			400			129,400
2013-07-02	2013-07-01	4	GRIECO WILLIAM	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.49		1,500		16,500
2013-07-02	2013-07-01	4	GRIECO WILLIAM	ECTE	Common Stock	A - Award	D			400			229,400
2013-07-02	2013-07-01	4	SMITH JAMES FRANCIS	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.49		1,500		16,500
2013-07-02	2013-07-01	4	SMITH JAMES FRANCIS	ECTE	Common Stock	A - Award	D			400			76,400
2013-07-02	2013-07-01	4	Doman Robert F	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	2.49		1,500		16,500
2013-07-02	2013-07-01	4	Doman Robert F	ECTE	Common Stock	A - Award	D			400			39,400
2013-04-11	2013-04-09	4	ENRIGHT VINCENT D	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	0.79		15,000		115,000
2013-04-11	2013-04-09	4	GRIECO WILLIAM	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	0.79		15,000		15,000
2013-04-11	2013-04-09	4	SMITH JAMES FRANCIS	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	0.79		15,000		15,000
2013-04-11	2013-04-09	4	Doman Robert F	ECTE	Nonqualified Stock Option (right to buy)	A - Award	D	0.79		15,000		15,000
2013-04-10	2013-04-09	4	ENRIGHT VINCENT D	ECTE	Common Stock	A - Award	D			4,000			129,000
2013-04-10	2013-04-09	4	GRIECO WILLIAM	ECTE	Common Stock	A - Award	D			4,000			229,000
2013-04-10	2013-04-09	4	SMITH JAMES FRANCIS	ECTE	Common Stock	A - Award	D			4,000			76,000
2013-04-10	2013-04-09	4	Doman Robert F	ECTE	Common Stock	A - Award	D			4,000			39,000
2013-03-25	2013-03-22	4	Doman Robert F	ECTE	Common Stock	P - Purchase	D		0.7974	15,000	12		35,000
2013-03-22	2013-03-21	4	GRIECO WILLIAM	ECTE	Common Stock	P - Purchase	D		0.7593	30,000	23		225,000
2013-03-14	2013-03-12	4	Doman Robert F	ECTE	Common Stock	A - Award	D			20,000			20,000
2013-01-11	2013-01-10	4	ENRIGHT VINCENT D	ECTE	Common Stock	A - Award	D			6,250			208,334
2013-01-11	2013-01-10	4	GRIECO WILLIAM	ECTE	Common Stock	A - Award	D			6,250			195,000
2013-01-11	2013-01-10	4	SMITH JAMES FRANCIS	ECTE	Common Stock	A - Award	D			6,250			72,000
2012-10-26	2012-10-24	4	SCHNITTKER CHRISTOPHER P.	ECTE	Common Stock	A - Award	D			31,250			125,000
2012-10-26	2012-10-24	4	SCHNITTKER CHRISTOPHER P.	ECTE	Common Stock	A - Award	D			31,250			125,000
2012-10-26	2012-10-24	4	MOONEY PATRICK T	ECTE	Common Stock	A - Award	D			150,000			2,025,000
2012-10-26	2012-10-24	4	BURKE KIMBERLY A	ECTE	Common Stock	A - Award	D			37,500			325,000
2012-10-26	2012-10-24	4	BURKE KIMBERLY A	ECTE	Common Stock	A - Award	D			37,500			287,500
2012-10-02	2012-09-30	4	ENRIGHT VINCENT D	ECTE	Common Stock	A - Award	D			6,250			202,084
2012-10-02	2012-09-30	4	GRIECO WILLIAM	ECTE	Common Stock	A - Award	D			6,250			188,750
2012-10-02	2012-09-30	4	SMITH JAMES FRANCIS	ECTE	Common Stock	A - Award	D			6,250			65,750
2012-08-23	2012-08-23	4	SMITH JAMES FRANCIS	ECTE	Common Stock	P - Purchase	D		1.4700	6,400	9		59,500
2012-08-23	2012-08-22	4	SMITH JAMES FRANCIS	ECTE	Common Stock	P - Purchase	D		1.4700	13,600	20		53,100
2012-07-03	2012-06-30	4	ENRIGHT VINCENT D	ECTE	Common Stock	A - Award	D			6,250			195,834
2012-07-03	2012-06-30	4	GRIECO WILLIAM	ECTE	Common Stock	A - Award	D			6,250			182,500
2012-07-03	2012-06-30	4	SMITH JAMES FRANCIS	ECTE	Common Stock	A - Award	D			6,250			39,500
2012-05-31	2012-05-30	4	MOONEY PATRICK T	ECTE	Common Stock	G - Gift	D			-625,907			1,875,000
2012-05-01	2012-04-27	4	SCHNITTKER CHRISTOPHER P.	ECTE	Common Stock	A - Award	D			31,250			62,500
2012-05-01	2012-04-27	4	MOONEY PATRICK T	ECTE	Common Stock	A - Award	D			150,000			2,500,907
2012-05-01	2012-04-27	4	BURKE KIMBERLY A	ECTE	Common Stock	A - Award	D			37,500			250,000
2012-01-31	2012-01-27	4	SCHNITTKER CHRISTOPHER P.	ECTE	Common Stock	A - Award	D			31,250			31,250
2012-01-31	2012-01-27	4	MOONEY PATRICK T	ECTE	Common Stock	A - Award	D			150,000			2,350,907
2012-01-31	2012-01-27	4	BURKE KIMBERLY A	ECTE	Common Stock	A - Award	D			37,500			212,500

Open market or private purchase of non-derivative or derivative security

Open market or private sale of non-derivative or derivative security

Grant, award, or other acquisition of securities from the company (such as an option)

Conversion of derivative

Sale or transfer of securities back to the company

Payment of exercise price or tax liability using portion of securities received from the company

Gift of securities by or to the insider

Equity swaps and similar hedging transactions

Exercise or conversion of derivative security received from the company (such as an option)

A transaction voluntarily reported on Form 4

Other (accompanied by a footnote describing the transaction)

ECTE / Echo Therapeutics Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5